DEBIOTECH SA

Company Snapshot

Founded: 1990
Entity Type: Private
Region: Switzerland
Headquarter: Lausanne, Switzerland
Key Geographics: Switzerland
Corporate Address: Avenue de Sévelin 28 CH-1004 Lausanne, Switzerland Tel. +41-21-623-6000 www.debiotech.com

Company Overview

Debiotech SA develops and designs medical devices. It has 40 license agreements and holds over 500 granted national patents. The company’s expertise is in drug delivery systems, dialysis technologies, and software as a medical device (SaMD).

DEBIOTECH SA In Reports

Global MedTech Healthcare IT Industry Competitive Landscape

BCC Research Market Analyst says global market for medical devices was valued at $810.4 billion in 2024 and is projected to reach $1.4 trillion by the end of 2030.

Smart Medical Devices: Global Markets

BCC Research Market Analyst says global market for smart medical devices is projected to grow from $87.7 billion in 2025 to reach $193.3 billion by the end of 2030.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

BCC Research Market Analyst says global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028 at a CAGR of 9.8%.

Company's Business Segments

  • Product : 3D Modelling, Prototyping, Mechanical Simulations, Micro-Mechanics, Firmware Software, Complex Fluidics, Others
  • Service : Project Coordination, Management, Usability Engineering, Verification, Certification, Others

Applications/End User Industries

  • Healthcare
  • Pharmaceuticals
  • Home Dialysis
AI Sentiment